Competitive landscape
Drugs aimed at the same indication, from approved to preclinical.
2 drugs for “B-cell Acute Lymphoblastic Leukemia”
Phase 3 1
- CTL019NOVARTIS AGB-cell Acute Lymphoblastic Leukemia
Phase 2/3 1
- MK-1045Merck & Co., Inc.B-cell Acute Lymphoblastic Leukemia
Drugs whose recorded indications name this term, by development stage. Indications come from registries and labels, so a drug can appear under related terms.